Skip to the main content.

Major Depressive Disorder


Case Studies

Here you can edit the background of the section

Key Takeaways

A three-year, four-protocol, pivotal study, requiring over 6,700 global participants, demanded the highest level of strategic planning, coordination, and precise execution to achieve on-time enrollment. With 336 sites in 34 countries, this was a large-scale effort.

To generate large-scale awareness and interest, BBK developed a robust centralized and localized advertising campaign that drove patients to sites in record numbers — boosting screening rates by over 50 percent and resulting in over 25,000 referrals in 30 months.  




Motivating a population that may be reluctant to commit to clinical trial participation

Navigating country-specific advertising requirements while implementing a highly complex global advertising outreach strategy

Competing for patient and physician mindshare within a heavily crowded treatment landscape


Solutions and Impact

Campaign elements included television, paid search, Facebook, streaming radio and gaming networks.

The three-year enrollment window allowed BBK to consistently optimize tactical outreach to meet the changing recruitment landscape — both as it pertained to available treatments and to the technological evolution and adoption of mobile devices by the majority of the population.

BBK anticipated and capitalized on the mobile revolution before competitors could react, optimizing outreach platforms that resulted in a 377% spike in website traffic and 14,879 new referrals over a 12-month period.

By stacking a number of highly targeted outreach tactics to maximize study exposure and engagement, BBK managed to increase total screening rates by over 50 percent.


  • Increase-Referrals_ICON-1 19,183 Referrals generated from television.

  • Increase-Referrals_ICON-1 2,341 Referrals generated from paid search.

  • Increase-Referrals_ICON-1 2,570 Referrals generated from mobile advertising.


Download the PDF version of this case study today:

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

October 12, 2021

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

December 13, 2021

Pediatric Boys with Duchenne Muscular Dystrophy — Rare and Gene Therapy — Phase 3B

case-studies-icon Case Studies

April 13, 2022

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.